Cargando…
SARS-CoV-2 Variants and Vaccines
Viral variants of concern may emerge with dangerous resistance to the immunity generated by the current vaccines to prevent coronavirus disease 2019 (Covid-19). Moreover, if some variants of concern have increased transmissibility or virulence, the importance of efficient public health measures and...
| Autores principales: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Massachusetts Medical Society
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262623/ https://www.ncbi.nlm.nih.gov/pubmed/34161052 http://dx.doi.org/10.1056/NEJMsr2105280 |
| _version_ | 1783719222231171072 |
|---|---|
| author | Krause, Philip R. Fleming, Thomas R. Longini, Ira M. Peto, Richard Briand, Sylvie Heymann, David L. Beral, Valerie Snape, Matthew D. Rees, Helen Ropero, Alba-Maria Balicer, Ran D. Cramer, Jakob P. Muñoz-Fontela, César Gruber, Marion Gaspar, Rogerio Singh, Jerome A. Subbarao, Kanta Van Kerkhove, Maria D. Swaminathan, Soumya Ryan, Michael J. Henao-Restrepo, Ana-Maria |
| author_facet | Krause, Philip R. Fleming, Thomas R. Longini, Ira M. Peto, Richard Briand, Sylvie Heymann, David L. Beral, Valerie Snape, Matthew D. Rees, Helen Ropero, Alba-Maria Balicer, Ran D. Cramer, Jakob P. Muñoz-Fontela, César Gruber, Marion Gaspar, Rogerio Singh, Jerome A. Subbarao, Kanta Van Kerkhove, Maria D. Swaminathan, Soumya Ryan, Michael J. Henao-Restrepo, Ana-Maria |
| author_sort | Krause, Philip R. |
| collection | PubMed |
| description | Viral variants of concern may emerge with dangerous resistance to the immunity generated by the current vaccines to prevent coronavirus disease 2019 (Covid-19). Moreover, if some variants of concern have increased transmissibility or virulence, the importance of efficient public health measures and vaccination programs will increase. The global response must be both timely and science based. |
| format | Online Article Text |
| id | pubmed-8262623 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Massachusetts Medical Society |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-82626232021-07-09 SARS-CoV-2 Variants and Vaccines Krause, Philip R. Fleming, Thomas R. Longini, Ira M. Peto, Richard Briand, Sylvie Heymann, David L. Beral, Valerie Snape, Matthew D. Rees, Helen Ropero, Alba-Maria Balicer, Ran D. Cramer, Jakob P. Muñoz-Fontela, César Gruber, Marion Gaspar, Rogerio Singh, Jerome A. Subbarao, Kanta Van Kerkhove, Maria D. Swaminathan, Soumya Ryan, Michael J. Henao-Restrepo, Ana-Maria N Engl J Med Special Report Viral variants of concern may emerge with dangerous resistance to the immunity generated by the current vaccines to prevent coronavirus disease 2019 (Covid-19). Moreover, if some variants of concern have increased transmissibility or virulence, the importance of efficient public health measures and vaccination programs will increase. The global response must be both timely and science based. Massachusetts Medical Society 2021-06-23 /pmc/articles/PMC8262623/ /pubmed/34161052 http://dx.doi.org/10.1056/NEJMsr2105280 Text en Copyright © 2021 Massachusetts Medical Society. All rights reserved. This article is made available via the PMC Open Access Subset for unrestricted re-use, except commercial resale, and analyses in any form or by any means with acknowledgment of the original source. These permissions are granted for the duration of the Covid-19 pandemic or until revoked in writing. Upon expiration of these permissions, PMC is granted a license to make this article available via PMC and Europe PMC, subject to existing copyright protections. |
| spellingShingle | Special Report Krause, Philip R. Fleming, Thomas R. Longini, Ira M. Peto, Richard Briand, Sylvie Heymann, David L. Beral, Valerie Snape, Matthew D. Rees, Helen Ropero, Alba-Maria Balicer, Ran D. Cramer, Jakob P. Muñoz-Fontela, César Gruber, Marion Gaspar, Rogerio Singh, Jerome A. Subbarao, Kanta Van Kerkhove, Maria D. Swaminathan, Soumya Ryan, Michael J. Henao-Restrepo, Ana-Maria SARS-CoV-2 Variants and Vaccines |
| title | SARS-CoV-2 Variants and Vaccines |
| title_full | SARS-CoV-2 Variants and Vaccines |
| title_fullStr | SARS-CoV-2 Variants and Vaccines |
| title_full_unstemmed | SARS-CoV-2 Variants and Vaccines |
| title_short | SARS-CoV-2 Variants and Vaccines |
| title_sort | sars-cov-2 variants and vaccines |
| topic | Special Report |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262623/ https://www.ncbi.nlm.nih.gov/pubmed/34161052 http://dx.doi.org/10.1056/NEJMsr2105280 |
| work_keys_str_mv | AT krausephilipr sarscov2variantsandvaccines AT flemingthomasr sarscov2variantsandvaccines AT longiniiram sarscov2variantsandvaccines AT petorichard sarscov2variantsandvaccines AT briandsylvie sarscov2variantsandvaccines AT heymanndavidl sarscov2variantsandvaccines AT beralvalerie sarscov2variantsandvaccines AT snapematthewd sarscov2variantsandvaccines AT reeshelen sarscov2variantsandvaccines AT roperoalbamaria sarscov2variantsandvaccines AT balicerrand sarscov2variantsandvaccines AT cramerjakobp sarscov2variantsandvaccines AT munozfontelacesar sarscov2variantsandvaccines AT grubermarion sarscov2variantsandvaccines AT gasparrogerio sarscov2variantsandvaccines AT singhjeromea sarscov2variantsandvaccines AT subbaraokanta sarscov2variantsandvaccines AT vankerkhovemariad sarscov2variantsandvaccines AT swaminathansoumya sarscov2variantsandvaccines AT ryanmichaelj sarscov2variantsandvaccines AT henaorestrepoanamaria sarscov2variantsandvaccines |